CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK
$490,236N01FY2014HDNIH
University Of Washington, Seattle WA
Investigators
Abstract
Conduct a Phase I clinical trial to test whether a new chemical entity such as 11-beta methyl nortestosterone dodecycarbonate will be well tolerated and will suppress gonadotropins pursuant to development of a contraceptive product for men.
View original record on NIH RePORTER →